Sunny Pharmtech Inc. (TPEX:6676)
Taiwan
· Delayed Price · Currency is TWD 14.35
+0.10 (0.70%)
Jun 27, 2025, 2:54 PM CST
Sunny Pharmtech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 138.02 | 270.56 | 222.63 | 229 | 241.72 | Upgrade
|
Short-Term Investments | - | - | 48.51 | 12.5 | - | Upgrade
|
Cash & Short-Term Investments | 138.02 | 270.56 | 271.14 | 241.5 | 241.72 | Upgrade
|
Cash Growth | -48.98% | -0.21% | 12.27% | -0.09% | -28.22% | Upgrade
|
Accounts Receivable | 49.34 | 56.35 | 28.77 | 63.63 | 39.18 | Upgrade
|
Other Receivables | 2.26 | 0.8 | 1.78 | 7.17 | 10.29 | Upgrade
|
Receivables | 51.6 | 57.15 | 30.55 | 70.8 | 49.47 | Upgrade
|
Inventory | 123.49 | 97.04 | 71.94 | 97.6 | 140.38 | Upgrade
|
Prepaid Expenses | 48.64 | 28.65 | 21.75 | 18.4 | 15.07 | Upgrade
|
Other Current Assets | 3.1 | 7.1 | 18.6 | 43.48 | 2.4 | Upgrade
|
Total Current Assets | 364.86 | 460.49 | 413.98 | 471.78 | 449.03 | Upgrade
|
Property, Plant & Equipment | 1,092 | 1,156 | 1,102 | 946.12 | 910.26 | Upgrade
|
Goodwill | 25.24 | 25.24 | 25.24 | 25.24 | 25.24 | Upgrade
|
Other Intangible Assets | 35.96 | 42.77 | 55.2 | 51.42 | 58.73 | Upgrade
|
Other Long-Term Assets | 69.2 | 27.91 | 32.76 | 100.16 | 56.34 | Upgrade
|
Total Assets | 1,587 | 1,712 | 1,630 | 1,595 | 1,500 | Upgrade
|
Accounts Payable | 16.88 | 26.13 | 12.34 | 23.17 | 17.22 | Upgrade
|
Accrued Expenses | 44.8 | 30.43 | 23.81 | 21.9 | 21.6 | Upgrade
|
Short-Term Debt | 20 | - | 190 | 50 | 46.72 | Upgrade
|
Current Portion of Long-Term Debt | 20.75 | 11.19 | 9.44 | 20.09 | 32.83 | Upgrade
|
Current Portion of Leases | 4.17 | 3.94 | 3.16 | 2.79 | 2.76 | Upgrade
|
Current Unearned Revenue | 32.5 | 19.19 | 12.48 | 10.87 | 7.19 | Upgrade
|
Other Current Liabilities | 25.85 | 20.95 | 29.03 | 36.89 | 16.49 | Upgrade
|
Total Current Liabilities | 164.94 | 111.83 | 280.25 | 165.7 | 144.81 | Upgrade
|
Long-Term Debt | 297.06 | 333.81 | 327.24 | 264.44 | 269.94 | Upgrade
|
Long-Term Leases | 44.31 | 42.49 | 32.86 | 28.98 | 31.77 | Upgrade
|
Long-Term Unearned Revenue | 27.13 | 17.07 | 12.74 | 1.46 | 1.46 | Upgrade
|
Other Long-Term Liabilities | 7.24 | 7.24 | 7.24 | 7.68 | 7.24 | Upgrade
|
Total Liabilities | 540.68 | 512.44 | 660.32 | 468.26 | 455.21 | Upgrade
|
Common Stock | 1,488 | 1,485 | 1,385 | 1,385 | 1,295 | Upgrade
|
Additional Paid-In Capital | 21.69 | 209.53 | 16.9 | 169.06 | 2.88 | Upgrade
|
Retained Earnings | -462.96 | -496.17 | -432.85 | -427.84 | -253.05 | Upgrade
|
Comprehensive Income & Other | 0.41 | 1.32 | - | - | - | Upgrade
|
Shareholders' Equity | 1,047 | 1,200 | 969.3 | 1,126 | 1,044 | Upgrade
|
Total Liabilities & Equity | 1,587 | 1,712 | 1,630 | 1,595 | 1,500 | Upgrade
|
Total Debt | 386.29 | 391.43 | 562.69 | 366.3 | 384.01 | Upgrade
|
Net Cash (Debt) | -248.27 | -120.87 | -291.55 | -124.8 | -142.29 | Upgrade
|
Net Cash Per Share | -1.67 | -0.85 | -2.10 | -0.93 | -1.10 | Upgrade
|
Filing Date Shares Outstanding | 148.76 | 148.53 | 138.53 | 138.53 | 129.46 | Upgrade
|
Total Common Shares Outstanding | 148.76 | 148.53 | 138.53 | 138.53 | 129.46 | Upgrade
|
Working Capital | 199.92 | 348.66 | 133.74 | 306.08 | 304.23 | Upgrade
|
Book Value Per Share | 7.04 | 8.08 | 7.00 | 8.13 | 8.07 | Upgrade
|
Tangible Book Value | 985.49 | 1,132 | 888.86 | 1,050 | 960.42 | Upgrade
|
Tangible Book Value Per Share | 6.62 | 7.62 | 6.42 | 7.58 | 7.42 | Upgrade
|
Buildings | 856.04 | 847.93 | 777.39 | 702.81 | 673.73 | Upgrade
|
Machinery | 856.02 | 822.27 | 587.06 | 512.13 | 471.67 | Upgrade
|
Construction In Progress | 2.69 | 4.44 | 162.91 | 64.94 | 7.5 | Upgrade
|
Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.